Actively Recruiting
Effect of iTBS on Children With ADHD
Led by First Affiliated Hospital of Zhejiang University · Updated on 2023-12-13
54
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Attention Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder characterized by persistent symptoms of attention deficit and/or hyperactivity/impulsivity . Currently, the first line drugs for treating ADHD are central stimulants such as Tomoxetine and Guanfaxine. However, there is a risk of drug abuse and misuse, which often affects sleep and appetite, only 50% of patients can fully tolerate. This project uses the iTBS stimulation on weekends, children with ADHD finish scale evaluation, magnetic resonance imaging analysis, and cognitive function before and after stimulation, This study explores its therapeutic effect on attention deficit in children and adolescents with ADHD.
CONDITIONS
Official Title
Effect of iTBS on Children With ADHD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of ADHD according to DSM-V
- Age between 6 and 12 years old, any gender
- Right-handed
- Han nationality or born in Han nationality region
- Disease duration longer than 6 months
- Webster children's intelligence score of 70 or higher
- Guardian agrees and signs informed consent form
You will not qualify if you...
- Presence of other mental disorders such as anxiety and depression
- Widespread developmental disorders or other neurological developmental disorders
- Serious diseases affecting important organs like heart and lungs
- Epilepsy or tic disorder
- Inability to tolerate or cooperate with rTMS treatment
- Use of psychoactive drugs, antipsychotics, antidepressants, or mood stabilizers within 3 months before enrollment or during treatment, except minimum effective dose of Tomoxetine (1.2-1.4 mg/kg/day)
- Webster's intelligence score below 70
- Implantation of metal or electronic devices in the body (excluding the oral cavity), such as pacemakers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Psychiatry, First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China, 310000
Actively Recruiting
Research Team
S
Shaohua Hu, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here